Management of hormone-resistant prostate cancer
Gibbons, R.P.
Progress in Clinical and Biological Research 303: 337-345
1989
ISSN/ISBN: 0361-7742 PMID: 2674995 Document Number: 331596
Document emailed within 1 workday
Related Documents
Roznovanu, S.L.ăc.ăm.; Amălinci, C.; Rădulescu, D.ţa. 2005: Molecular mechanisms in hormone-resistant prostate cancer Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 109(3): 577-583Vorob'ev, N.A.; Nosov, A.K.; Vorob'ev, A.V.; Moiseenko, V.M. 2010: New perspectives in the drug therapy of hormone-resistant prostate cancer Voprosy Onkologii 56(6): 645-653
Gomella, L.G.; Petrylak, D.P.; Shayegan, B. 2014: Current management of advanced and castration resistant prostate cancer Canadian Journal of Urology 21(2 Supp 1): 1-6
Kelly, W.K. 1998: Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer European Urology 34(Suppl): 18-23
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Colombel, M.; Davin, J.-L.; Filleul, A.; Rousseau, C. 2004: Diagnosis and management of advanced hormone-refractory prostate cancer: results of a practice survey on 301 French urologists Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(2): 182-188
St-Arnaud, R.; Lachance, R.; Dupont, A.; Labrie, F. 1986: Stimulation of the circulating levels of glycoprotein hormone alpha-subunit after combined administration of a luteinizing hormone-releasing hormone (LHRH) agonist and flutamide in patients with cancer of the prostate Clinical and Investigative Medicine. Medecine Clinique et Experimentale 9(4): 215-221
Shimizu, T.; Shibata, Y.; Uchida, T.; Satoh, J. 1993: Severe flare-up in a prostate cancer patient treated with luteinizing hormone-releasing hormone analogue depot Hinyokika Kiyo. Acta Urologica Japonica 39(10): 953-955
Ngo, L.S.M.; Yeo, A.; Wong, A.S.C.; Tay, M.Hiang. 2007: Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore Annals of the Academy of Medicine Singapore 36(10): 811-814
Dondi, D.; Limonta, P.; Moretti, R.M.; Marelli, M.M.; Garattini, E.; Motta, M. 1994: Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop Cancer Research 54(15): 4091-4095
Rosino, A.; Ballester, I.; Tudela, J.án.; González-Billalabeitia, E. 2018: Chemotherapy in metastatic castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 676-684
Naito, S.; Shiota, M. 2014: The concept and mechanisms of castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2090-2094
Vázquez-Alonso, F.; Puche-Sanz, I.; Cózar-Olmo, J.é M. 2018: Recommendations for follow up in castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 735-742
Suzuki, H.; Ito, H. 2002: Hormone dependency of prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 59-64
Ojeda, A.V.; Ledo, M.ía.J.é; Alvarez-Ossorio, J.é L.ís. 2018: Sequencing and combination of agents in castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 711-720
Miyake, H.; Fujisawa, M. 2014: Antisense oligodeoxynucleotide therapy for castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2121-2125
Replogle-Schwab, T.S.; Schwab, E.D.; Pienta, K.J. 1997: Development of doxorubicin resistant rat prostate cancer cell lines Anticancer Research 17(6d): 4535-4538
Hall, R.R. 1987: Deferred hormone treatment in prostate cancer Progress in Clinical and Biological Research 243b: 439-440
Maeno, A.; Habuchi, T. 2016: Current status of castration-resistant prostate cancer translational research Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 40-44
Bourlon, M.T.; Glodé, L.M.; Crawford, E.D. 2014: Base of the skull metastases in metastatic castration-resistant prostate cancer Oncology 28(12): 1115-1116; 1124